Target intelligence / Profile preview

Endosomal and lysosomal nucleic acid

Molecular classification
Other
01

Overview

Endosomal and lysosomal nucleic acids refer to DNA and RNA molecules located within the endocytic pathway, where they serve as ligands for Pattern Recognition Receptors (PRRs), specifically Toll-like receptors 3, 7, 8, and 9 (Saas et al., 2023). These nucleic acids can be of exogenous origin, such as viral or bacterial genomes, or endogenous origin, such as self-DNA/RNA released during cell death or through autophagy. The recognition of these molecules is a fundamental component of the innate immune response, triggering the production of type I interferons and other pro-inflammatory cytokines to combat infection. However, the persistent presence or improper sensing of self-nucleic acids in these compartments is a hallmark of autoimmune diseases like systemic lupus erythematosus (SLE) and Sjögren's syndrome. Therapeutic agents like hydroxychloroquine target these nucleic acids by binding to them directly or by neutralizing the acidic environment of the endolysosome, thereby preventing the activation of the TLR signaling cascade and reducing chronic inflammation (Schrezenmeier & Dörner, 2020).

Other names
Endosomal DNAEndosomal RNALysosomal DNALysosomal RNASelf-nucleic acidToll-like receptor ligand
02

Mechanism of action

Inhibition of Toll-like receptor (TLR) signaling through direct binding to nucleic acids (masking them from receptors) and elevation of endosomal/lysosomal pH, which prevents the proteolytic activation of TLRs and the processing of their ligands (Schrezenmeier & Dörner, 2020; Kuznik et al., 2011).

03

Biological functions

Immune responseSignal transductionPattern recognitionOther
04

Disease associations

InflammationInfectionOther
05

Safety considerations

Retinal toxicity (retinopathy)QT interval prolongationCardiomyopathyNeuromyopathy
06

Interacting drugs

Hydroxychloroquine

2 more in the full profile.

07

Biomarkers

Anti-double-stranded DNA (anti-dsDNA) antibodiesType I interferon signatureSerum complement levels (C3, C4)Erythrocyte sedimentation rate (ESR)

Beyond the preview

Go deeper on Endosomal and lysosomal nucleic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endosomal and lysosomal nucleic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call